| Financial Year |
March 31 2023 |
| Monetary Funds |
23,358,789.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
165,338,487.14 |
| Advances to Suppliers |
24,409,396.42 |
| Other Receivables |
284,922,998.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
10,216.59 |
| Dividend Receivable |
-- |
| Inventories |
189,872,802.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,188,863.49 |
| Total Current Assets |
906,975,757.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
19,799,424.01 |
| Long-term Equity Investment |
97,594,428.29 |
| Investment Properties |
179,716,357.60 |
| Fixed Assetes |
1,361,053,703.70 |
| Under-construction Projects |
95,401,528.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
442,319,185.05 |
| R&D expenses |
69,549,301.52 |
| Goodwill |
326,416,321.27 |
| Long-Term Deferred and Prepaid Expenses |
29,730,289.67 |
| Deferred Income Tax Assets |
221,152,651.63 |
| Other Non-Current Assets |
939,675,000.57 |
| Sub-Total of Non-Current Assets |
3,819,433,331.37 |
| Total Assets |
4,726,409,089.25 |
| Short-Term Loans |
1,449,428,903.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
16,141,878.52 |
| Accounts Payable |
374,445,551.44 |
| Accounts Received In Advance |
12,786,819.76 |
| Employee Compensation Payable |
28,039,155.39 |
| Taxes Payable |
50,378,105.91 |
| Interest Payable |
235,572,779.03 |
| Dividend Payable |
-- |
| Other payables |
551,782,922.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
452,981,096.41 |
| Other Current Liabilities |
76,019,267.56 |
| Sub-Total of Current Liabilities |
3,028,274,389.08 |
| Long-term Loans |
315,227,807.11 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
63,109,872.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
95,137,542.60 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
635,995,164.57 |
| Total Liabilities |
3,664,269,553.65 |
| Paid-In Capital(Or Share Stock) |
1,152,214,592.00 |
| Capital Surplus |
3,236,284,793.92 |
| Surplus Reserve |
49,559,707.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,375,015,965.55 |
| Minority Stockholder's Interest |
843,115.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,061,296,419.70 |
| Owner's Equity（Stockholder's Equity） |
1,062,139,535.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,726,409,089.25 |
